课题基金 / 基金详情

项目摘要

项目成果

CHARLES S FUCHS的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):本申请提议耶鲁大学成为新成立的NCI国家临床试验网络下的网络领导学术参与站点(LAPS)。作为一名学生,耶鲁大学将。促进和倡导耶鲁大学综合癌症中心(YCC)的NCTN临床研究;2.继续扩大NCTN试验的应计范围,并向YCC会员提供广泛的机会参加这些重要的国家试验;3. 提供必要的科学领导,以推进NCI在NCTN系统中资助的研究事业,并领导将推进癌症治疗和护理标准的重要试验;4. 为这些NCTN临床试验提供转化科学和实验室支持;5. 培训和指导NCTN小组中的青年研究人员,帮助他们提供下一代科学领导
英文摘要
DESCRIPTION (provided by applicant): This application proposes that Yale University become a Network Lead Academic Participating Site (LAPS) under the newly established NCI National Clinical Trials Network. As an LAPS Yale University will 1. Promote and advocate for NCTN clinical research at the Yale Comprehensive Cancer Center (YCC); 2.continue expanding accrual to NCTN trials and provide broad based access to these important national trials to YCC membership; 3. Provide the scientific leadership necessary in order to advance the cause of NCI funded research in the NCTN system and lead important trials that will advance cancer treatment and standard of care; 4. Provide the translational science and laboratory support for these NCTN clinical trials; 5. Train and mentor Young Investigators in the NCTN groups and help them to provide the next generation of scientific leadership
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of Celecoxib and Inflammation on Survival in Stage III Colon Cancer
  • 批准号:
    8505928
  • 项目类别:
  • 资助金额:
    $63.33万
  • 财政年份:
    2013
  • 负责人:
    CHARLES S FUCHS
  • 依托单位:
Impact of Celecoxib and Inflammation on Survival in Stage III Colon Cancer
  • 批准号:
    8912878
  • 项目类别:
  • 资助金额:
    $79.18万
  • 财政年份:
    2013
  • 负责人:
    CHARLES S FUCHS
  • 依托单位:
Impact of Celecoxib and Inflammation on Survival in Stage III Colon Cancer
  • 批准号:
    9341076
  • 项目类别:
  • 资助金额:
    $104.15万
  • 财政年份:
    2013
  • 负责人:
    CHARLES S FUCHS
  • 依托单位:
Impact of Celecoxib and Inflammation on Survival in Stage III Colon Cancer
  • 批准号:
    8737807
  • 项目类别:
  • 资助金额:
    $72.07万
  • 财政年份:
    2013
  • 负责人:
    CHARLES S FUCHS
  • 依托单位:
海外基金